LP419634-3
Loprazolam
Active
Description
Loprazolam is an imidazobenzodiazepine with anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. Loprazolam is recommended as a short-term therapy only, due to adverse events associated with the drug including dependence and withdrawal symptoms. It is a positive modulator of GABA-A receptor that enhances the inhibitory neurotransmission. It is not an FDA-approved drug.[DRUGBANK: DB13643] Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Loprazolam
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2020-07-14
- Construct for LOINC Short Name
- Loprazolam
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP419634-3 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP419634-3
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
it-IT | Italian (Italy) | Loprazolam |
nl-NL | Dutch (Netherlands) | loprazolam |
es-ES | Spanish (Spain) | Loprazolam |
zh-CN | Chinese (China) | 氯普唑仑 Synonyms: CAS 61197-73-7 |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright